TTR and amyloidosis: TTR yields quality X-ray diffracting crystals, and the determination of the structure, unlike most of the biochemical assays used to evaluate the ligands’ efficiency against TTR amyloidosis, is essentially unambiguous, usually performed by molecular replacement using a TTR high-resolution initial model.